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Abstract
Background: Fluoroquinolones are extensively used antibiotics that induce DNA double-strand
breaks (DSBs) by trapping DNA gyrase and topoisomerase IV on DNA. This effect is usually
evaluated using biochemical or molecular procedures, but these are not effective at the single-cell
level. We assessed ciprofloxacin (CIP)-induced chromosomal DNA breakage in single-cell
Escherichia coli by direct visualization of the DNA fragments that diffused from the nucleoid
obtained after bacterial lysis in an agarose microgel on a slide.
Results: Exposing the E. coli strain TG1 to CIP starting at a minimum inhibitory concentration
(MIC) of 0.012 μg/ml and at increasing doses for 40 min increased the DNA fragmentation
progressively. DNA damage started to be detectable at the MIC dose. At a dose of 1 μg/ml of CIP,
DNA damage was visualized clearly immediately after processing, and the DNA fragmentation
increased progressively with the antibiotic incubation time. The level of DNA damage was much
higher when the bacteria were taken from liquid LB broth than from solid LB agar. CIP treatment
produced a progressively slower rate of DNA damage in bacteria in the stationary phase than in
the exponentially growing phase. Removing the antibiotic after the 40 min incubation resulted in
progressive DSB repair activity with time. The magnitude of DNA repair was inversely related to
CIP dose and was noticeable after incubation with CIP at 0.1 μg/ml but scarce after 10 μg/ml. The
repair activity was not strictly related to viability. Four E. coli strains with identified mechanisms of
reduced sensitivity to CIP were assessed using this procedure and produced DNA fragmentation
levels that were inversely related to MIC dose, except those with very high MIC dose.
Conclusion: This procedure for determining DNA fragmentation is a simple and rapid test for
studying and evaluating the effect of quinolones.
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Background
Fluoroquinolones are broad-spectrum antibacterial
agents that are used widely to treat a variety of infections,
such as gonococcal infections, osteomyelitis, enteric, and
respiratory and urinary tract infections. Ciprofloxacin
(CIP) is one of the most consumed fluoroquinolones
worldwide [1,2]. The type II topoisomerases DNA gyrase
and topoisomerase IV are the target of quinolones [3,4].
DNA gyrase is the preferential target in gram-negative bac-
teria such as E. coli, whereas topoisomerase IV is affected
mainly in gram-positive bacteria [5]. These enzymes
induce transient DNA double-strand breaks (DSBs) on
bacterial chromosomes, which either introduce negative
supercoiling, as in the case of DNA gyrase, or relax super-
coiling and decatenate-replicated daughter chromosomes,
as in the case of topoisomerase IV [3-5]. DNA gyrase is a
tetramer with two GyrA and two GyrB subunits, and
topoisomerase IV comprises two ParC and two ParE sub-
units. After DSB induction, the topoisomerase passes
through the DNA duplex, seals the break, and releases
DNA. During this process, a transient covalent link is
established between the GyrA or the ParC subunits and
the 5' end of each DNA break [3,5].
Quinolones bind rapidly to the DNA topoisomerases
attached to DNA, producing ternary complexes compris-
ing quinolone-topoisomerase-DNA. These complexes
promptly block DNA replication and RNA transcription,
an action that inhibits cell growth but does not clearly
explain the cell killing by quinolones [5-7]. After forma-
tion of the ternary complex, a DSB is produced by topoi-
somerase, but bound quinolone inhibits the subsequent
ligation of the DNA ends by trapping the topoisomerase
on DNA to the GyrA or ParC proteins through a covalent
bond of the 5' ends. These products are called cleaved
complexes and are distributed throughout the bacterial
chromosome. When using first-generation quinolones
such us nalidixic acid, DSBs are constrained initially by
the proteins from the cleaved complexes, and this process
can be reversed by removing the quinolone, adding EDTA,
or mild heat treatment. Cell killing is relatively slow, and
the rate of killing seems to correlate with later massive
chromosomal DNA fragmentation mediated by a putative
protein suicide factor, whose synthesis may be blocked by
chloramphenicol. In contrast, a high concentration of
fluoroquinolones such as CIP or gatifloxacin produces
rapid cell death and chromosomal DNA fragmentation,
processes that are not protected by chloramphenicol and
thus are protein synthesis independent [6,7]. In this case,
DSBs from the cleaved complexes behave as irreversible
products possibly because of the drug-mediated dissocia-
tion of topoisomerase subunits, and the DNA breaks are
released from the protein constraint, thereby fragmenting
the chromosome. Bactericidal antibiotics, including the
quinolone norfloxacin, may induce the production of
hydroxyl radicals that can cause extensive oxidative cellu-
lar damage, including secondary DNA injury, which may
contribute to bacterial death [8,9].
Quinolone resistance results essentially from target mod-
ification caused by mutations in the genes encoding the
subunits of DNA gyrase and topoisomerase IV, especially
in the quinolone resistance-determining region (QRDR)
[10-12]. Several mutations may coexist in the same or in
different subunits and may produce high-level resistance.
Changes in drug permeation or overexpression of efflux
pumps may also be involved and, in combination with
QRDR mutations, may contribute to high-level resistance
[10-12]. Several recent studies indicate that target protec-
tion through plasmid-mediated quinolone-resistance
genes also may play a significant role, and its prevalence
is increasing worldwide [13]. The existence of fluoroqui-
nolone-inactivating enzymes, like a variant of the gene
that encodes aminoglycoside acetyltransferase AAC(6')-
Ib, has been proposed [14]. This enzyme variant would
reduce the activity of both aminoglycosides and CIP.
Given the extended use of fluoroquinolones, especially
CIP, a more thorough understanding of their activity is
needed. Because chromosomal DNA fragmentation is the
main mechanism that correlates with cell killing [5-7], it
is the parameter of choice to assess fluoroquinolone activ-
ity. We have recently developed a kit that allows the sim-
ple and rapid assessment of the presence of fragmented
DNA at the single-cell level in micro-organisms [15]. Cells
immersed in an inert microgel on a slide are lysed, stained
with a highly sensitive DNA fluorochrome, and visualized
with a fluorescence microscope. The nucleoids with frag-
mented DNA are discriminated clearly by their peripheral
halo of diffused DNA fragments. The greater the fragmen-
tation, the greater the number of DNA spots and the
greater the circular surface area of diffusion evident in this
assay. Here we show the significant technical value of our
procedure for determining the activity of fluoroquinolo-
nes, particularly for detecting chromosomal DNA damage
and repair after CIP treatment in E. coli.
Methods
Cultures
Chromosomal DNA fragmentation in situ was assayed in
the TG1 E. coli strain, which was grown routinely in Luria
Bertani (LB) broth (1% Bacto-tryptone, 0.5% yeast extract,
0.5% NaCl) or on LB agar at 37°C in aerobic conditions.
E. coli TG1 [genotype: F traD36 LacIq (lacZ)M15] proAB/
supE  (hsdMmcrB)5(rkmk  McrB)  thi  (lac-proAB). Cell
growth in liquid cultures was evaluated by monitoring
turbidity at OD600 using a spectrophotometer (Unicam
8625, Cambridge, UK). The minimum inhibitory concen-
tration (MIC) was determined using the E-test (AB Bio-
disk, Solna Sweden) according to manufacturer's
instructions. Viability was determined by colony counting
after sequential dilutions and plating. To determine theBMC Microbiology 2009, 9:69 http://www.biomedcentral.com/1471-2180/9/69
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percentage of viable cells, the number of cells seeded on
the plate was counted using a cytometric camera.
Experiments
Three different experiments were performed with TG1 E.
coli, all in triplicate. Typical experiments are presented. In
the first, several colonies of TG1 E. coli were grown over-
night on LB agar plates and then resuspended in LB broth
at an OD600 of 0.05 and grown to an OD600 of 0.8. The col-
onies were then incubated with 0, 0.003, 0.006, 0.008,
0.012, 0.02, 0.04, 0.08, 0.1, 0.5, or 1 μg/ml CIP (Sigma)
in 15 ml Falcon tubes containing 4 ml of LB broth for 40
min at 37°C with aeration and shaking, and then proc-
essed to measure the chromosomal DNA fragmentation.
In the second experiment, TG1 E. coli was removed from cul-
ture in LB agar, resuspended in LB broth at an OD600 of 0.5,
and treated with 1 μg/ml CIP in LB broth at 37°C with aera-
tion and shaking. Aliquots were removed after 0, 5, 10, 15,
20, 30, and 40 min of incubation, and processed to measure
DNA fragmentation. The time needed to prepare the micro-
gel with the cells enclosed, before the slide was immersed in
the lysing solution, was 8 min (see next section). In the
results, this time must be added to each incubation period.
To complete this experiment, TG1 E. coli were cultured in liq-
uid LB broth at 37°C for 23 h with aeration and shaking, and
the growth was monitored by measuring the turbidity
(OD600). The liquid cultures started at an OD600 of 0.05.
Aliquots were removed during the exponentially growing
phase at 3 h (i.e., at an OD600 of 0.52) and during the station-
ary phase at 7 h (OD600: 1.20), 9 h (OD600: 1.52) and 23 h
(OD600: 1.84). At the end of each designated time, 1 μg/ml
of CIP was added directly to the aliquot, and the aliquot was
incubated at 37°C for 0 and 5 min, and then processed to
measure the DNA fragmentation.
In the third experiment, the micro-organisms were grown
overnight on LB agar plates, resuspended in LB broth at an
OD600 of 0.05, grown to an OD600 of 0.8, and then incu-
bated with 10, 1, or 0.1 μg/ml CIP in LB broth for 40 min
at 37°C. After the incubation, the CIP was removed from
the medium by centrifuging the bacteria and washing in
plain LB broth. The bacteria were incubated at 37°C in LB
broth with aeration and shaking, and aliquots were
removed at 0, 1.5, 3, 4, 5, and 24 h. For the 0.1 μg/ml dose
of CIP, the bacteria were also incubated for 6 h. One aliquot
was used to measure the DNA fragmentation, and another
was plated on LB agar at 37°C to measure the viability after
24 h of culture. Cultures without CIP and with CIP incor-
porated in the new LB medium added after washing after
the initial CIP treatment were included and processed
along with each dose and for the various incubation times.
Bacterial strains with low CIP sensitivity
Besides the experiments with TG1, DNA fragmentation
was measured in four E. coli strains whose low sensitivity
to CIP and underlying mechanisms are known. These
included strains with mutations in the QRDR region from
GyrA and ParC [16]. The isolates were C-15 (Ser83Leu
from GyrA; CIP MIC = 0.25 μg/ml); 1273 (Ser83Leu and
Asp87Tyr from GyrA; CIP MIC: 8.0 μg/ml), and 1383
(Ser83Leu and Asp87Tyr from GyrA together with
Ser80Ile and Glu84Lys from ParC; CIP MIC: 128 μg/ml),
and the control strain C-20 with no mutation in the
QRDR region (CIP MIC: 0.007 μg/ml). The strain J53 with
the plasmid-mediated quinolone-resistance gene qnrA1
(CIP MIC: 0.25 μg/ml) and its control strain J53 without
the plasmid were also examined [17]. These strains were
exposed to CIP at the MIC dose, at 10× and 100× the MIC
dose, and at 0.5× and 0.25× the MIC dose for 40 min at
37°C in the exponentially growing phase, and DNA frag-
mentation was determined.
Determination of DNA fragmentation
The Micro-Halomax®  kit for fluorescence microscopy
(Halotech DNA SL, Madrid, Spain) was used. A thorough
description has been published previously [15]. Essen-
tially, an aliquot of each sample was diluted to a concen-
tration of 5–10 million micro-organisms/ml in LB
medium. The kit includes 0.5 ml snap cap microfuge
tubes containing gelled aliquots of low-melting point aga-
rose. The tube was placed in a water bath at 90–100°C for
about 5 min to melt the agarose completely and then
placed in a water bath at 37°C. Twenty-five microlitres of
the diluted sample was added to the tube and mixed with
the melted agarose. A 20 μl aliquot of the sample-agarose
mixture was pipetted onto a precoated slide, and the sam-
ple was covered with a 22 mm × 22 mm coverslip. The
slide was placed on a cold plate in the refrigerator (4°C)
for 5 min to allow the agarose to produce a microgel with
the trapped intact cells inside. The coverslip was removed
gently, and the slide was immediately immersed horizon-
tally in 10 ml of the lysing solution for 5 min at 37°C. The
slide was washed horizontally in a tray with abundant dis-
tilled water for 3 min, dehydrated by incubating horizon-
tally in cold (-20°C) ethanol of increasing concentration
(70%, 90%, and 100%) for 3 min each, and air-dried in
an oven.
The dried slide was incubated in a microwave oven at 750
W for 4 min, and the DNA was stained with 25 μl of the
fluorochrome SYBR Gold (Molecular Probes, Eugene, OR,
USA) diluted 1:100 in TBE buffer (0.09 M Tris-borate,
0.002M EDTA, pH 7.5) for 5 min in the dark.
Images were viewed under an epifluorescence microscope
(Nikon E800), with a 100× objective and appropriate flu-
orescence filters, and the images were acquired using a
high-sensitivity CCD camera (KX32ME, Apogee Instru-
ments, Roseville, CA, USA). Groups of 16-bit digital
images were obtained at each experimental time under
similar conditions and stored as TIFF files. Image analysisBMC Microbiology 2009, 9:69 http://www.biomedcentral.com/1471-2180/9/69
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was performed using a macro designed with Visilog 5.1
software (Noesis, Gif sur Yvette, France). This macro
allows for thresholding and background subtraction, and
delineates the circular area of diffusion of the DNA frag-
ments from nucleoids. The width delimitated between the
edge of the nucleoid and the circumference that limits the
circular peripheral area of spreading of DNA fragments is
the simplest parameter to estimate DNA fragmentation
level after CIP treatment and was measured in μm. At each
experimental time, 50–125 nucleoids were evaluated.
Statistical analysis
Because the data did not follow a normal distribution as
ascertained by the Kolmogorov-Smirnov test, the non-
parametric Mann-Whitney U test was performed to com-
pare the groups. Significance was defined as P < 0.05.
Results
Dose response
The  E. coli strain TG1 (CIP MIC of 0.012 μg/ml) was
exposed to increasing doses of CIP in liquid LB medium for
40 min at 37°C (Fig. 1). Doses less than the MIC did not
result is visible DNA fragments, even after increasing the
incubation time with the antibiotic to 90 min (Fig. 1b). The
MIC dose resulted in a clear effect: nucleoids appeared
compact but with few peripheral DNA fragments (Fig. 1c).
As the dose increased, the number of DSBs increased grad-
ually, which was reflected in progressively more DNA frag-
ments and their elevated surface showing peripheral
diffusion from the nucleoid (Figs 1d and 1e). After the 0.5
μg/ml dose, all nucleoids appeared massively fragmented
as small DNA spots that diffused widely from their original
place in the bacteria (Fig. 1f). The 1 μg/ml dose resulted in
nucleoids that appeared similar to those obtained after 0.5
μg/ml. The degree of fragmentation tended to be homoge-
neous after each dose, probably because of the relative sim-
ilarity in the response to the antibiotic between the
different bacteria. The DNA fragments always appeared as
small spots, independent of the dose.
The width of the dispersion of the fragments from the
boundary of the nucleoid was quantified using an image
analysis system; this measure is a simple and reliable
quantitative parameter that reflects the level of CIP-
induced DNA damage (Table 1). Differences were signifi-
cant between the doses tested from 0.012 μg/ml, except
between 0.012 μg/ml and 0.02 μg/ml, between 0.04 μg/
ml and 0.08 μg/ml, and between 0.5 μg/ml and 1 μg/ml.
Using the images obtained, the nucleoids were catego-
rized into five classes of damage, as shown in Fig. 2 and
Table 1: class 0: undamaged, dose of 0 to 0.008 μg/ml
(Figs 1a and 1b); class I: low damage level, dose of 0.012
or 0.02 μg/ml (Fig. 1c); class II: intermediate level, dose of
0.04 or 0.08 μg/ml (Fig. 1d); class III: high level, dose of
0.1 μg/ml (Fig. 1e); and class IV: massive fragmentation,
doses of 0.5 or 1 μg/ml or higher (Fig. 1f). This latter class
of damage was practically undistinguishable from that
shown by nucleoids with extensive DNA fragmentation
always present spontaneously in cultures [15]. Classifica-
tion into classes is standard practice in mutagenesis stud-
ies and provides a perceptive description that is especially
useful when heterogeneity in the DNA damage rank is evi-
dent between the different nucleoids, as observed in the
DNA repair experiments.
Incubation time
To determine the minimum incubation time needed to
detect a DNA-breakage effect, the TG1 E. coli were col-
lected from LB agar and exposed in liquid LB to 1 μg/ml
CIP for 0, 5, 10, 15, 20, 30, and 40 min. The microgel
preparation time before immersion in the lysing solution
(8 min) must be added to these times because the antibi-
otic may enter the bacteria and act during this period.
Detectable but subtle damage was apparent after 0 min
(class I: diffusion width 1.7 ± 0.2 μm) (Fig. 3); this subtle
damage appeared as nucleoids with some peripheral DNA
fragments unlike in the untreated control cells. As the
Dose-response effect of CIP on nucleoids from the E. coli  strain TG1 Figure 1
Dose-response effect of CIP on nucleoids from the E. 
coli strain TG1. After 40 min incubation with CIP, the cells 
were processed with the Micro-Halomax® kit and stained 
with SYBR Gold. a: Control untreated cells;b: 0.008 μg/ml; 
c: 0.012 μg/ml, i.e., the MIC dose; d: 0.04 μg/ml; e: 0.1 μg/ml; 
f: 0.5 μg/ml.BMC Microbiology 2009, 9:69 http://www.biomedcentral.com/1471-2180/9/69
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incubation time increased, the level of DNA damage
increased progressively to class II after 2.5 min (2.8 ± 1.0
μm) and class III after 15 min (5.2 ± 1.0 μm); nucleoids
appeared massively fragmented after 30 min (class IV, 6.5
± 1.1 μm) (Fig. 3). As in the dose-response study, the DNA
damage intensity also tended to be homogeneous in the
different nucleoids at each sample time.
The DNA fragmentation level did not differ between bac-
teria incubated with the antibiotic at room temperature or
at 37°C, or with or without agitation. Interestingly, TG1
grown previously in LB broth instead of LB agar and tested
in the exponentially growing phase produced the most
DNA fragmentation (class IV) after 0 min; i.e., immedi-
ately after the 8 min of microgel preparing.
To investigate why the DNA damage level was dependent
on the previous culture conditions, TG1 was grown in LB
broth for 23 h, and the OD600 was monitored. Aliquots
were removed after different culture times and incubated
with 1 μg/ml CIP for 0 and 5 min (adding the 8 min of
microgel preparation) (Fig. 4). After 3 h of culture (i.e., in
the exponentially growing phase), all nucleoids were class
IV after 0 and 5 min, as described above. After 7 h, the cul-
ture had achieved the stationary phase, and the nucleoids
appeared mainly as class II (89.4%) and a few of them as
class I after 0 min of incubation, whereas most (97.8%)
Table 1: Dose-response effect of CIP on TG1 E. coli 
chromosomal DNA analyzed with the Micro-Halomax® kit.
Dose (μg/ml) Width of dispersion (μm) Class Range
0-
0.003 - 0 0
0.006 -
0.008 -
0.012 1.3 ± 0.3 I ≤ 2.0
0.02 1.6 ± 0.3
0.04 2.5 ± 0.4 II 2.1 – 3.7
0.08 3.3 ± 0.4
0.1 5.1 ± 1.0 III 3.8 – 5.7
0.5 7.8 ± 1.4 IV ≥ 5.8
1 8.8 ± 1.6
The width of the halo of dispersion of DNA fragments is presented in 
μm (mean ± standard deviation). The extent of DNA damage was 
classified according to the width of the dispersion.
Nucleoids from E. coli strain TG1 with progressively  increased DNA fragmentation after incubation with increas- ing doses of CIP Figure 2
Nucleoids from E. coli strain TG1 with progressively 
increased DNA fragmentation after incubation with 
increasing doses of CIP. 0: undamaged; I: low damage 
level; II: intermediate damage; III: high damage level; IV: mas-
sive fragmentation.
Effect of the incubation time at a dose of 1 μg/ml of CIP Figure 3
Effect of the incubation time at a dose of 1 μg/ml of 
CIP. The DNA fragmentation level is categorized by the 
width of the halo of diffusion of the DNA fragments emerg-
ing from nucleoids of E. coli strain TG1.
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DNA fragmentation in nucleoids from E. coli strain TG1 exposed to CIP in different culture times Figure 4
DNA fragmentation in nucleoids from E. coli strain TG1 exposed to CIP in different culture times. The growth 
curve of the bacteria, evaluated by monitoring turbidity at OD600, is presented above. The distribution of the frequencies of the 
diffusion widths of DNA fragments from the nucleoids were categorized into the five classes 0 to IV described in Table 1 and 
Fig. 2. Aliquots from a batch culture were removed at 3 h (exponentially growing phase) and at 7, 9, and 23 h (stationary 
phase), incubated with 1 μg/ml CIP for 0 (i.e., technical processing time of 8 min) (medium) and 5 min (below), and then 
processed to determine the DNA fragmentation.


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were class IV after 5 min. Aliquots removed after 9 h (i.e.,
stationary phase) showed nucleoids as classes I (84.0%)
and 0 (16.0%) after 0 min, and class III (98.4%) after 5
min incubation with CIP. The same result occurred after
23 h of culture. This experiment suggests that the growing
conditions influence the speed of the CIP effect, which
becomes increasingly slower when the bacteria are pro-
gressing into the stationary phase.
Evolution of DNA damage
The TG1 E. coli strain was exposed to three different doses
of CIP, 10, 1, and 0.1 μg/ml, for 40 min. After this treat-
ment, the antibiotic was washed out, and the bacteria
were incubated for 0, 1.5, 3, 4, 5, and 24 h (Fig. 5).
After exposure to the highest dose (10 μg/ml), all nucle-
oids were extremely fragmented, i.e., class IV. The DSB
repair was limited and clearly noticeable only after 4 h;
82.5% of nucleoids were of class III after 5 h. Remarkably,
all the nucleoids from the bacteria observed after 24 h
showed massive fragmentation (class IV). Viability was
very low after 0, 1.5, 3, and 4 h, and zero after 5 and 24 h
(Fig. 5a).
Immediately after incubating with the 1 μg/ml dose, all
nucleoids were class IV. A higher repair level was observed
than after the highest dose, predominantly class III
(58.7%) after 4 h, class I (41.0%) after 5 h, and class I
(47.1%) after 24 h. Apparently repaired nucleoids with-
Repair of CIP (10 μg/ml) induced DNA fragmentation Figure 5
Repair of CIP (10 μg/ml) induced DNA fragmentation. The distribution of the frequencies of the diffusion widths from 
the nucleoids were categorized according to the five classes of fragmentation level (0 to IV) presented in Table 1 and Fig. 2. 
The different repair times after exposure of TG1 E. coli to three doses of CIP (a: 10 μg/ml, b: 1 μg/ml, and c: 0.1 μg/ml) for 40 
min are presented. Viability (%) is indicated next to each repair time. Each dose is shown with its respective culture (above) in 
which the antibiotic was present during the incubation time.
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out diffusing DNA fragments (10.2%) were visualized
after 5 h, and this increased to 22.2% after 24 h. However,
the viability was very low, as in the experiment with the
highest dose (Fig. 5b).
In contrast to the results at the higher doses, repair activity
was evident in the cultures exposed continuously to 0.1
μg/ml of CIP for the various times (Fig. 5c); 53.0% of
nucleoids were class III after 4 h, and 31% were class I and
31% class 0 after 6 h. This latter time was assessed further
in this experiment. The frequency of class 0 increased
from 2.3% after 4 h to 67.3% after 24 h. In all cases, via-
bility was very low or zero. Removing the drug resulted in
faster repair kinetics, predominantly of class II (76.2%)
after 1.5 h and class 0 (81.0%) after 5 h (Fig. 5c). The
nucleoid pattern was similar to that of the untreated con-
trol cells after 24 h. Viability was initially very low, 2–4%
after 4–6 h, and increased to 56.8% after 24 h (Fig. 5c).
Thus, we found no clear relationship between the extent
of repair of CIP-induced DNA breakage and cell viability.
Evaluation of strains with known mechanisms of low 
sensitivity to CIP
The other E. coli strains used have been described previ-
ously [16]. They include strains with one amino acid sub-
stitution mutation in GyrA (C-15), two substitution
mutations in GyrA (1273), and two substitution muta-
tions in GyrA and another two in ParC (1383). The more
mutations, the greater the resistance level, as reflected in
the MIC values (Table 2). We also evaluated a strain with
a qnrA1 plasmid (J53 qnrA1) [17] (Table 2). Doses lower
than the MIC never resulted in visible DNA fragments.
Thus, in strains with a MIC of 0.25 μg/ml (C-15 and J53
qnrA1), the MIC dose caused little DNA fragmentation in
all bacteria (class I), whereas doses of 10× and 100× the
MIC caused massive DNA fragmentation (class IV) (Table
2; Fig. 6). This behaviour is similar to that of the fully sen-
sitive control strains but was shifted to a higher MIC. The
1273 strain did not show a clear effect at the MIC dose (8
μg/ml) but appeared as class I after 10× and class II after
100× of the MIC dose (Table 2; Fig. 7). The 1383 strain
has a high MIC (128 μg/ml) and showed no DNA damage
at any dose (Table 2; Fig. 7).
Discussion
CIP-induced chromosomal DNA fragmentation was
assayed in situ in E. coli using the Micro-Halomax® kit
[15]. We grew the samples in LB agar because this is sim-
pler and is used routinely in clinical microbiology labora-
tories. The sample is scratched, diluted in LB broth to an
OD600 of 0.05, and incubated with CIP in 4 ml of liquid
LB in a 15 ml Falcon tube at 37°C with aeration. Incuba-
tion in a 1.5 ml Eppendorf tube with 24 μl of LB broth at
room temperature (22°C) and without aeration does not
modify the kinetics of DNA fragmentation induced by 1
μg/ml of CIP. We observed similar results in the TG1
strain and in three other E. coli-sensitive samples. Further
confirmation in other sensitive strains could simplify the
protocol for assessing E. coli sensitivity or resistance to CIP
in the clinic.
Incubating TG1 with CIP for 40 min before technical
processing produced a clear dose-response effect in chro-
mosomal DNA fragmentation, and the damage level was
similar in the different nucleoids. The effect on DNA was
evident starting at the MIC dose, and DNA fragments were
always visualized as spots of relatively small size, inde-
pendently of the dose. The fragment size after oxolinic
acid or norfloxacin treatment of E. coli has been estimated
at 50 to 100 kb; i.e., the presumed size of the DNA loops
of the nucleoid [18-20]. Our result suggests that the DNA
fragments liberated from the nucleoid are of fairly regular
Table 2: DNA fragmentation levels obtained in strains of E. coli with different susceptibilities to CIP.
CIP dose
Strain Mutations MIC MIC 1× MIC 10× MIC 100×
C-20 - 0.007 1.5 ± 0.3 6.7 ± 0.8 10.3 ± 2.5
C-15 Ser83Leu from GyrA 0.25 1.7 ± 0.3 6.2 ± 0.7 8.7 ± 1.1
1273 Ser83Leu and Asp87Tyr from GyrA 8 0 1.8 ± 0.3 2.7 ± 0.4
1383 Ser83Leu and Asp87Tyr from GyrA and Ser80Ile and Glu84Lys from ParC 128 0 0 0
J53 - 0.007 1.8 ± 0.8 9.2 ± 1.2 10.4 ± 2.0
J53qnrA1 Plasmid gene J53qnrA1 0.25 1.9 ± 0.4 9.5 ± 1.3 9.8 ± 0.9
The level of fragmentation obtained by different CIP doses is indicated by the width of the halo of dispersion of DNA fragments and is measured in 
μm (mean ± standard deviation). MIC is in μg/ml.BMC Microbiology 2009, 9:69 http://www.biomedcentral.com/1471-2180/9/69
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size and that more fragments are released as the CIP dose
increases. It also supports the possibility of clusters of
preferential DNA gyrase cleavage sites [19]. It is possible
that doses smaller than the MIC could induce a small
amount of DSBs, which could be spaced widely in the dif-
ferent domains but not cause spreading of the fragments.
In our previous report, a CIP dose of 0.012 μg/ml pro-
duced slightly more damage than in the present study
[15]. This is probably because of the harsher lysing condi-
tions in our previous study, which may have caused addi-
tional DNA damage. This was corrected in the conditions
used in our current study.
Adding 1 μg/ml of CIP to TG1 in LB broth and instantane-
ous processing using our technique produced just barely
detectable DNA fragmentation. Taking TG1 from LB agar
reduces the extent of damage. DNA damage increases pro-
gressively with incubation time, and a 30 min incubation
is needed to achieve the maximum level of DNA fragmen-
tation. Remarkably, when the bacteria came from expo-
nentially growing cultures in LB broth, the highest DNA
fragmentation level was observed immediately (0 min).
These results suggest that the CIP effect on DNA is cumu-
lative with time and that its velocity is dependent on the
growing conditions. We confirmed this hypothesis by
analyzing aliquots removed periodically from a batch cul-
ture incubated with 1 μg/ml CIP for 0 and 5 min. The
DNA fragmentation level declined progressively as the
bacteria proceed into the stationary phase.
Most E. coli cells divide uniformly in exponentially grow-
ing cultures but stop dividing when they achieve the sta-
tionary phase [21]. Bacteria grown in LB agar should be
heterogeneous with regard to the growing phase, both
exponential and stationary. The MIC is an average of the
bacterial sensitivity to the antibiotic, which reflects the
different effect of CIP on DNA. The DNA fragmentation
yield is homogeneous among the nucleoids in exponen-
tially growing TG1 but is slower and tends to be more het-
erogeneous in the stationary phase. This greater
heterogeneity was evident after short incubation with 1
μg/ml CIP but tended to be homogeneous after 40 min of
treatment.
Pulse field gel electrophoresis shows that the norfloxacin-
induced fragmentation in E. coli nucleoids is low in the
stationary phase of growth [20]. This phenomenon could
reflect decreased drug uptake, increased drug efflux,
downregulation of topoisomerases, or a more tightly
packed nucleoid structure as demonstrated by atomic
force microscopy [22]. Using our procedure, we have also
observed more compacted nucleoids in the stationary
phase. The most probable explanation is the activation of
multidrug transporters that exclude fluoroquinolones,
which is mediated by quorum-sensing signals. In fact, the
quorum-sensing transcription factor SdiA from E. coli is
regulated in a density-dependent manner, and its overpro-
duction upregulates AcrAB, which increases resistance to
quinolones and other antibiotics [23].
The lysing solution causes protein denaturation, so theo-
retically, the sensitivity-resistance assay is adequate to
investigate sensitivity to fluoroquinolones at the relevant
Representative images of the DNA fragmentation induced by  CIP in E. coli strains C-20 and C-15 Figure 6
Representative images of the DNA fragmentation 
induced by CIP in E. coli strains C-20 and C-15. Left: 
MIC dose; medium: 10× MIC dose; right: 100× MIC dose. 
Above: control C-20 strain. a: 0.007 μg/ml; b: 0.07 μg/ml; c: 
0.7 μg/ml. Below: C-15 strain. d: 0.25 μg/ml;e: 2.5 μg/ml; f: 
25 μg/ml.
Representative images of the DNA fragmentation induced by  CIP in E. coli 1273 and 1383 strains Figure 7
Representative images of the DNA fragmentation 
induced by CIP in E. coli 1273 and 1383 strains. Left: 
MIC dose; medium: 10× MIC dose; right: 100× MIC dose. 
Above: 1273 strain. a: 8 μg/ml; b: 80 μg/ml; c: 800 μg/ml. 
Below: 1383 strain. d: 128 μg/ml; e: 1280 μg/ml; f: 12800 
μg/ml.BMC Microbiology 2009, 9:69 http://www.biomedcentral.com/1471-2180/9/69
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doses. CIP-mediated DSBs are natively unconstrained and
are considered irreversible and lethal. In the case of first-
generation quinolones such as nalidixic acid, the tech-
nique would artificially unconstrain DSBs that are natu-
rally confined in the cleaved complex. If so, both
reversible non-lethal DSBs and later lethal unconstrained
DSBs should be detected without but cannot be differen-
tiated in the assay. Addition of the chelating agent EDTA
seems to reverse the cleaved complex formation by qui-
nolones [7], possibly because incubation with EDTA
before lysis allows the resealing of the reversible DNA
breaks so that only the irreversible DSBs would be
detected.
CIP-induced DSBs were not totally irreversible, and a pro-
gressive repair activity with time was evident in TG1. The
magnitude of DNA repair was inversely related to dose
and was noticeable after a dose of 0.1 μg/ml but scarce
after a dose of 10 μg/ml. This repair was evident when the
antibiotic was removed after the 40 min incubation and
when TG1 was exposed continuously to the low dose (0.1
μg/ml) without CIP removal. The progressive spontane-
ous CIP degradation or inactivation with time in culture
cannot be discounted, and the effect of CIP could be
smaller despite being long lasting, especially if added at a
low dose.
E. coli may repair DSBs by RecA-dependent homologous
recombination (HR) [24]. CIP-induced DSBs could be
processed to single-stranded DNA, a target for RecA,
which promotes recombinatorial repair and induction of
the SOS response through activation of the autocleavage
of the LexA repressor [25,26]. Rapid lethality is increased
by the lexA Ind-allele, and recombination-deficient E. coli
strains are hypersensitive to quinolones [27]. The RecBCD
nuclease/helicase also seems to be required for SOS
induction by quinolones, as demonstrated with nalidixic
acid [28]. Interestingly, DSBs may also be repaired by a
non-homologous end joining (NHEJ) mechanism that
comprises break recognition, end processing, and ligation
activities. Although E. coli lacks a NHEJ pathway, its pres-
ence has been demonstrated in mycobacteria and bacillus
[29]. Nevertheless, NHEJ deficiency caused by the loss of
Ku and ligD has no effect on the sensitivity to quinolones
of Mycobacterium smegmatis [30].
Repair of quinolone-induced DSBs probably needs more
complex processing because both 5' ends of cleaved DNA
are linked covalently via phosphotyrosine bonds to a
topoisomerase subunit. These DNA-protein crosslinks
(DPCs) could be eliminated in coordination with the
nucleotide excision repair (NER) mechanism. The urvABC
nuclease, which initiates the NER pathway in E. coli, may
incise DPCs with or without previous proteolytic degrada-
tion of the crosslinked protein [31]. Accordingly, NER
seems to be involved in CIP-induced DNA damage, as
demonstrated in deficient E. coli strains [27]. Although
both NER and HR may commit to the repair of DPCs, it
has been proposed recently that DPCs with crosslinked
proteins of sizes < 12–14 kDa are repaired by NER,
whereas oversized DPCs are processed exclusively by
RecBCD-dependent HR [32]. If confirmed, the later mech-
anism should be preferred in the repair of DPCs involving
topoisomerase subunits.
The repair activity was not strictly related to viability.
Although the nucleoid may appear normal after repair,
particularly at the low dose (0.1 μg/ml), the bacteria may
not be fully viable, possibly because of the lack of total
fidelity in restitution and the SOS response, resulting in
an error-prone repair [26]. Some misrepaired lesions
could lead to a non-viable cell. The DNA repair experi-
ments emphasize the importance of achieving the neces-
sary concentrations over a prolonged time for the
successful clinical effect of quinolones.
DNA repair is not cited as a mechanism of decreased sen-
sitivity to quinolones. Nevertheless, E. coli mutants with
constitutive RecA expression or defective SOS induction
may survive longer [27]. It is possible that dysfunction of
certain DNA repair processes may lead to a low sensitivity
to CIP, and this could increase the effect of other coexist-
ing mechanisms of resistance. This possibility needs to be
explored.
It is expected that resistance to fluoroquinolones would
hinder the production of DSBs, which are slowly or rarely
produced. Because DSBs appear to correlate strongly with
the MIC and viability, the DNA fragmentation assay
should detect resistance accurately. The preliminary study
of the DNA fragmentation analysis in the four E. coli
strains with low sensitivity to CIP suggests that this is the
case. The 1273 strain did not show a clear effect at the MIC
dose and had a lower DNA fragmentation level than that
observed in other strains at the same multiple of MIC
dose. This phenomenon could be related to the accumu-
lation of multiple resistance mechanisms, such as multi-
ple mutations in different topoisomerase subunits and in
conjunction with altered outer membrane proteins and
lipopolysaccharide, and increased activity of efflux sys-
tems [33]. Since only J-53 and J-53qnrA1 strains are iso-
genic, the other strains could have other differences that
could influence the results. Moreover, the growth inhibi-
tion may not be dependent on inhibition of the topoi-
somerases leading to DNA fragmentation and the
possibility exists of unknown mechanisms of action.
Conclusion
The DNA fragmentation assay may be a simple and rapid
test to evaluate the sensitivity and resistance to quinolo-Publish with BioMed Central    and   every 
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nes. We are currently performing more comprehensive
assessment of different characterized CIP-resistant and
CIP-sensitive E. coli strains and in clinical samples.
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